Targeted Gene Panel Sequencing for Molecular Diagnosis of Kallmann Syndrome and Normosmic Idiopathic Hypogonadotropic Hypogonadism

Abstract

Background Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is classified either as Kallmann syndrome (KS) with anosmia or normosmic idiopathic hypogonadotropic hypogonadism (nIHH) and caused by mutations in more than 30 different genes. Recent advances in next-generation sequencing technologies have revolutionized the identification of causative genes by using massively parallel sequencing of multiple samples. This study was performed to establish the genetic etiology of IGD using a targeted gene panel sequencing of 69 known human IGD genes.

Methods This study included 28 patients with IGD from 27 independent families. Exomes were captured using customized SureSelect kit (Agilent Technologies) and sequenced on the Miseq platform (Illumina, Inc.), which includes a 163,269 bp region spanning 69 genes.

Results Four pathogenic and six likely pathogenic sequence variants were identified in 11 patients from 10 of the 27 families (37%) included in the study. We identified two known pathogenic mutations in CHD7 and PROKR2 from two male patients (7.4%). Novel sequence variants were also identified in 10 probands (37%) in CHD7, SOX3, ANOS1, FGFR1, and TACR3. Of these, while eight variants (29.6%) were presumed to be pathogenic or likely pathogenic, the remaining two were classified as variants of uncertain significance. Of the two pre-pubertal males with anosmia, one harbored a novel heterozygous splice site variant in FGFR1.

Conclusions The overall diagnostic yield was 37% of the patients who had undergone targeted gene panel sequencing. This approach enables rapid, cost-effective, and comprehensive genetic screening in patients with KS and nIHH.

Key words

anosmia - normosmic idiopathic hypogonadotropic hypogonadism - kallmann syndrome - next-generation sequencing - targeted gene panel

*These two authors contributed equally.

• References

• 1 Stamou MI, Cox KH, Crowley Jr WF. Discovering genes essential to the hypothalamic regulation of human reproduction using a human disease model: Adjusting to life in the “-Omics” era. Endocr Rev 2016; 2016: 4-22
• 2 Boehm U, Bouloux PM, Dattani MT. et al. Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2015; 11: 547-564
• 3 Sykiotis GP, Plummer L, Hughes VA. et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 2010; 107: 15140-15144
• 4 Pitteloud N, Quinton R, Pearce S. et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 2007; 117: 457-463
• 5 Costa-Barbosa FA, Balasubramanian R, Keefe KW. et al. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab 2013; 98: E943-E953
• 6 Au MG, Crowley Jr WF, Buck CL. Genetic counseling for isolated GnRH deficiency. Mol Cell Endocrinol 2011; 346: 102-109
• 7 Pedersen-White JR, Chorich LP, Bick DP. et al. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Mol Hum Reprod 2008; 14: 367-370
• 8 Buonocore F, Achermann JC. Human sex development: targeted technologies to improve diagnosis. Genome Biol 2016; 17: 257
• 9 Turan I, Hutchins BI, Hacihamdioglu B. et al. CCDC141 Mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2017; 102: 1816-1825
• 10 Kotan LD, Hutchins BI, Ozkan Y. et al. Mutations in FEZF1 cause kallmann syndrome. Am J Hum Genet 2014; 95: 326-331
• 11 Quaynor SD, Bosley ME, Duckworth CG. et al. Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and kallmann syndrome. Mol Cell Endocrinol 2016; 437: 86-96
• 12 Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics 2013; 68: 81-88
• 13 Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23 doi:10.1136/adc.45.239.13
• 14 Doty RL, Marcus A, William Lee W. Development of the 12–item cross–Cultural smell identification test (CC–SIT). Laryngoscope 1996; 106: 353-356
• 15 Layman LC, Lee EJ, Peak DB. et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med 1997; 337: 607-611
• 16 Achermann JC, Weiss J, Lee EJ. et al. Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 2001; 179: 89-96
• 17 Lofrano-Porto A, Barra GB, Giacomini LA. et al. Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med 2007; 357: 897-904
• 18 Achermann JC, Jameson JL. Advances in the molecular genetics of hypogonadotropic hypogonadism. J Pediatr Endocrinol Metab 2001; 14: 3-15
• 19 Yanase T, Takayanagi R, Oba K. et al. New mutations of DAX-1 genes in two Japanese patients with X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1996; 81: 530-535
• 20 Martin MG, Lindberg I, Solorzano-Vargas RS. et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology 2013; 145: 138-148
• 21 Reynaud R, Barlier A, Vallette-Kasic S. et al. An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 2005; 90: 4880-4887
• 22 Kelberman D, Rizzoti K, Avilion A. et al. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest 2006; 116: 2442-2455 58
• 23 Izumi Y, Suzuki E, Kanzaki S. et al. Genome-wide copy number analysis and systematic mutation screening in 58 patients with hypogonadotropic hypogonadism. Fertil Steril 2014; 102: 1130-1136 e1133
• 24 Salian-Mehta S, Xu M, Knox AJ. et al. Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2014; 99: 1452-1460
• 25 Kim HG, Kurth I, Lan F. et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2008; 83: 511-519
• 26 Miraoui H, Dwyer AA, Sykiotis GP. et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet 2013; 92: 725-743
• 27 Tornberg J, Sykiotis GP, Keefe K. et al. Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism. Proc Natl Acad Sci U S A 2011; 108: 11524-11529
• 28 Quaynor SD, Ko EK, Chorich LP. et al. NELF knockout is associated with impaired pubertal development and subfertility. Mol Cell Endocrinol 2015; 407: 26-36
• 29 Cariboni A, Davidson K, Rakic S. et al. Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: Implications for the aetiology of hypogonadotropic hypogonadism. Hum Mol Genet 2011; 20: 336-344
• 30 Kotan LD, Cooper C, Darcan S. et al. Idiopathic hypogonadotropic hypogonadism caused by inactivating mutations in SRA1. J Clin Res Pediatr Endocrinol 2016; 8: 125-134
• 31 Chew S, Balasubramanian R, Chan WM. et al. A novel syndrome caused by the E410K amino acid substitution in the neuronal beta-tubulin isotype 3. Brain 2013; 136: 522-535
• 32 Kim HG, Ahn JW, Kurth I. et al. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2010; 87: 465-479
• 33 Moya-Plana A, Villanueva C, Laccourreye O. et al. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency. Eur J Endocrinol 2013; 168: 31-37
• 34 Messina A, Ferraris N, Wray S. et al. Dysregulation of Semaphorin7A/beta1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet 2011; 20: 4759-4774
• 35 Falardeau J, Chung WC, Beenken A. et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 2008; 118: 2822-2831
• 36 Villanueva C, de Roux N. FGFR1 mutations in Kallmann syndrome. Front Horm Res 2010; 39: 51-61
• 37 Bouligand J, Ghervan C, Trabado S. et al. Genetics defects in GNRH1: A paradigm of hypothalamic congenital gonadotropin deficiency. Brain Res 2010; 1364: 3-9
• 38 Silveira LF, Stewart PM, Thomas M. et al. Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: Human GnRHR “knockout”. J Clin Endocrinol Metab 2002; 87: 2973-2977
• 39 Dedes I. Kisspeptins and the control of gonadotrophin secretion. Syst Biol Reprod Med 2012; 58: 121-128
• 40 Aminzadeh M, Kim HG, Layman LC. et al. Rarer syndromes characterized by hypogonadotropic hypogonadism. Front Horm Res 2010; 39: 154-167
• 41 Beneduzzi D, Iyer AK, Trarbach EB. et al. Mutational analysis of the necdin gene in patients with congenital isolated hypogonadotropic hypogonadism. Eur J Endocrinol 2011; 165: 145-150
• 42 Young J, Bouligand J, Francou B. et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab 2010; 95: 2287-2295
• 43 Margolin DH, Kousi M, Chan YM. et al. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N Engl J Med 2013; 368: 1992-2003
• 44 Tarnutzer AA, Gerth-Kahlert C, Timmann D. et al. Boucher-Neuhauser syndrome: Cerebellar degeneration, chorioretinal dystrophy and hypogonadotropic hypogonadism: Two novel cases and a review of 40 cases from the literature. J Neurol 2015; 262: 194-202
• 45 Wolf NI, Vanderver A, van Spaendonk RM. et al. Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology 2014; 83: 1898-1905
• 46 Handley MT, Aligianis IA. RAB3GAP1, RAB3GAP2 and RAB18: Disease genes in Micro and Martsolf syndromes. Biochem Soc Trans 2012; 40: 1394-1397
• 47 Ganos C, Hersheson J, Adams M. et al. The 4H syndrome due to RNF216 mutation. Parkinsonism Relat Disord 2015; 21: 1122-1123
• 48 Shi CH, Schisler JC, Rubel CE. et al. Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum Mol Genet 2014; 23: 1013-1024
• 49 Khan SA, Muhammad N, Khan MA. et al. Genetics of human bardet-biedl syndrome, an updates. Clin Genet 2016; 90: 3-15
• 50 Alsters SI, Goldstone AP, Buxton JL. et al. Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism. PLoS One 2015; 10: e0131417
• 51 Alazami AM, Al-Saif A, Al-Semari A. et al. Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am J Hum Genet 2008; 83: 684-691
• 52 Tata B, Huijbregts L, Jacquier S. et al. Haploinsufficiency of Dmxl2, encoding a synaptic protein, causes infertility associated with a loss of GnRH neurons in mouse. PLoS Biol 2014; 12: e1001952
• 53 Cukier P, Wright H, Rulfs T. et al. Molecular and gene network analysis of thyroid transcription factor 1 (TTF1) and enhanced at puberty (EAP1) genes in patients with GnRH-dependent pubertal disorders. Horm Res Paediatr 2013; 80: 257-266
• 54 Harakalova M, van den Boogaard MJ, Sinke R. et al. X-exome sequencing identifies a HDAC8 variant in a large pedigree with X-linked intellectual disability, truncal obesity, gynaecomastia, hypogonadism and unusual face. J Med Genet 2012; 49: 539-543
• 55 Francucci CM, Gatti C, Camilletti A. et al. Hypogonadism and reduced bone mineral density in heterozygous H63D mutation in the HFE gene: An unusual presentation of hereditary hemochromatosis. J Androl 2007; 28: 21-26
• 56 Spiegel R, Shalev SA, Adawi A. et al. ANE syndrome caused by mutated RBM28 gene: A novel etiology of combined pituitary hormone deficiency. Eur J Endocrinol 2010; 162: 1021-1025
• 57 Pingault V, Bodereau V, Baral V. et al. Loss-of-function mutations in SOX10 cause Kallmann syndrome with deafness. Am J Hum Genet 2013; 92: 707-724
• 58 McLaren W, Gil L, Hunt SE. et al. The Ensembl Variant Effect Predictor. Genome Biol 2016; 17: 122
• 59 Sherry ST, Ward MH, Kholodov M. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308-311
• 60 Landrum MJ, Lee JM, Riley GR. et al. ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014; 42: D980-D985
• 61 Stenson PD, Mort M, Ball EV. et al. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 2014; 133: 1-9
• 62 Zook JM, Chapman B, Wang J. et al. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls. Nature biotechnology 2014; 32: 246-251
• 63 Richards S, Aziz N, Bale S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424
• 64 Brito VN, Batista MC, Borges MF. et al. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 1999; 84: 3539-3544
• 65 Bilan F, Legendre M, Charraud V. et al. Complete screening of 50 patients with CHARGE syndrome for anomalies in the CHD7 gene using a denaturing high-performance liquid chromatography-based protocol: New guidelines and a proposal for routine diagnosis. J Mol Diagn 2012; 14: 46-55
• 66 Cole LW, Sidis Y, Zhang C. et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: Molecular genetics and clinical spectrum. J Clin Endocrinol Metab 2008; 93: 3551-3559
• 67 Collignon J, Sockanathan S, Hacker A. et al. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 1996; 122: 509-520
• 68 Laumonnier F, Ronce N, Hamel BC. et al. Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 2002; 71: 1450-1455
• 69 Stagi S, Lapi E, Pantaleo M. et al. A SOX3 (Xq26. 3-27.3) duplication in a boy with growth hormone deficiency, ocular dyspraxia, and intellectual disability: A long-term follow-up and literature review. Hormones (Athens) 2014; 13: 552-560
• 70 Woods KS, Cundall M, Turton J. et al. Over-and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 2005; 76: 833-849
• 71 Alkelai A, Olender T, Dode C. et al. Next-generation sequencing of patients with congenital anosmia. Eur J Hum Genet 2017; 25: 1377-1387